Question: CRISPR-Cas9 delivery methods for in vivo therapeutic editing
LNP CRISPR delivery for CNS applications feasibility
Needs new evidence1 verified (technical)
0/4 publication-ready
Findings metrics
—
total
—
verified
—
pending
—
rejected
Question: CRISPR-Cas9 delivery methods for in vivo therapeutic editing
—
total
—
verified
—
pending
—
rejected